Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

October 04, 2023 12:58 (London Time)

Syros Pharmaceuticals

Youtube Subscribe

...

Sector: Biotechnology
Ticker: SYRS
Sentiment: 0.7783
MarketCap: 58,195,229.0
High: 3.25 Low: 2.8

Open: 3.19 Close: 2.8 Change: -0.39

The best way to get information about Syros Pharmaceuticals Company Inc Stock: Use an AI.

How much time have you spent trying to decide whether investing in Syros Pharmaceuticals? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Syros Pharmaceuticals are: …

Concept Map

...

Semantic Network

...

Stock Summary

Syros Pharmaceuticals shares fall 18% on staff cuts, ceo retirement. Pfizer terminating license agreement with Syros for sickle cell disease and beta-thalassemia. Company tightens focus on key drug candidate tamibar.

Today's Summary

Syros Pharmaceuticals shares fall 18% on staff cuts, ceo retirement - MarketWatch. CEO leaves a deep and lasting impact on our company and the patients globally who we hope to treat Shares fell after the company cut more than one- third of its staff. Syros Pharmaceuticals to cut 35% of staff; CEO Simonian to retire - MarketWatch. Pfizer terminating license agreement with Syros for sickle cell disease and beta-thalassemia. Company tightens focus on key drug candidate tamibarotene.

Today's News

Syros Pharmaceuticals shares fall 18% on staff cuts, ceo retirement - MarketWatch. CEO leaves a deep and lasting impact on our company and the patients globally who we hope to treat Shares fell after the company cut more than one- third of its staff. Syros Pharmaceuticals to cut 35% of staff; CEO Simonian to retire - MarketWatch. Pfizer terminating license agreement with Syros for sickle cell disease and beta-thalassemia. Company tightens focus on key drug candidate tamibarotene.

Stock Profile

" Syros Pharmaceuticals shares fall 18% on staff cuts, ceo retirement - MarketWatch. CEO leaves a deep and lasting impact on our company and the patients globally who we hope to treat Shares fell after the company cut more than one- third of its staff. Syros Pharmaceuticals to cut 35% of staff; CEO Simonian to retire - MarketWatch. Pfizer terminating license agreement with Syros for sickle cell disease and beta-thalassemia. Company tightens focus on key drug candidate tamibarotene."

Keywords

The game is changing. There is a new strategy to evaluate Syros Pharmaceuticals fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Syros Pharmaceuticals are: Syros, staff, cut, Pharmaceuticals, MarketWatch, CEO, company, and the most common words in the summary are: excipient, pharmaceutical, phase, syros, sodium, stock, job, . One of the sentences in the summary was: Company tightens focus on key drug candidate tamibarotene.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #excipient #pharmaceutical #phase #syros #sodium #stock #job.

Read more →

Related Results

...
December 17, 2023 2:18 (London Time)

Syros Pharmaceuticals

Syros Pharmaceuticals Inc (SYRS) stock is down -7.74% while the S&P 500 has risen 0.57% as of 2:01 PM on Wednesday, Dec 13. Syros is laying off 35% …
Sector: Biotechnology
Ticker: SYRS
Sentiment: 0.5267
MarketCap: 87,639,015.0
High: 4.48 Low: 4.05

Open: 4.34 Close: 4.16 Change: -0.18

Read more →
...
October 04, 2023 12:58 (London Time)

Syros Pharmaceuticals

Syros Pharmaceuticals shares fall 18% on staff cuts, ceo retirement - MarketWatch. CEO leaves a deep and lasting impact on our company and the patie…
Sector: Biotechnology
Ticker: SYRS
Sentiment: 0.7783
MarketCap: 58,195,229.0
High: 3.25 Low: 2.8

Open: 3.19 Close: 2.8 Change: -0.39

Read more →